Richard B. Womer, MD
Richard B. Womer, MD
Professor of Pediatrics at the Children's Hospital of Philadelphia
Department: Pediatrics
Contact information
CHOP
34th & CIVIC CENTER
4399
Philadelphia, PA 19104
34th & CIVIC CENTER
4399
Philadelphia, PA 19104
Office: 2159779779
Email:
RWOMER@MAIL.MED.UPENN.EDU
RWOMER@MAIL.MED.UPENN.EDU
Education:
B.A. (Biology)
University of Rochester, 1974.
M.D.
University of Rochester, 1978.
Permanent linkB.A. (Biology)
University of Rochester, 1974.
M.D.
University of Rochester, 1978.
Selected Publications
Hill-Kayser CE, Bagatell R, Reilly A, Womer R, Balamuth N, Both S, Lustig R, Tochner Z: Outcomes after proton therapy for pediatric patients with cancers of the head and neck region. American Society for Radiation Oncology Annual Meeting May 2013.Hill-Kayser CE, Tochner Z, Both S, Lustig R, Reilly A, Balamuth NJ, Womer RB, Maris JM, Grupp S, Bagatell R: Proton versus photon radiation therapy for patients with high-risk neuroblastoma: The need for a customized approach. Pediatric Blood and Cancer Page: in press, 2013.
Weiss AR, Lyden ER, Anderson JR, Hawkins DS, Spunt SL, Walterhouse DO, Wolden SL, Parham DM, Rodeberg DA, Kao SC, Womer RB: Histologic and clinical characteristics can guide staging evaluations for children and adolescents with rhabdomyosarcoma: A report from the Children's Oncology Group. Journal of Clinical Oncology Page: in press, 2013.
DuBois SG, Krailo M, Gebhardt M, Donaldson S, Marcus KJ, Dormans J, Shamberger RC, Sailer S, Nicholas R, Healey J, Tarbell N, Devidas M, Meyer J, Granowetter L, Womer RB, Bernstein M, Marina N, Grier HE: Local and distant failure according to mode of local control in patients with localized Ewing sarcoma of bone: A report from the Children’s Oncology Group. Connective Tissue Oncology Society Annual Meeting, Prague, CZ November 2012.
Albritton K, Krailo M, Marina NM, Granowetter L, Grier HE, Womer RB, Janeway KA, Najera SL, Gorlick RG: Older age as an independent prognostic factor in Ewing sarcoma treated on Children’s Oncology Group protocols. Connective Tissue Oncology Society Annual Meeting November 2012.
DuBois SG, Krailo M, Gebhardt M, Donaldson S, Marcus KJ, Dormans J, Shamberger RC, Sailer S, Nicholas R, Healey J, Tarbell N, Devidas M, Meyer J, Granowetter L, Womer RB, Bernstein M, Marina N, Grier HE: Local control strategies in patients with localized Ewing sarcoma of bone: A report from the Children's Oncology Group. American Society of Clinical Oncology Annual Meeting, Chicago, IL June 2012.
Kopp L, Bernstein M, Schwartz C, Ebb D, Krailo M, Grier H, Meyers P, Wexler L, Marina N, Womer R, Janeway K, Gorlick R, Lipschultz SE: The effects of dexrazoxane on cardiac status and second malignant neoplasms (SMN) in doxorubicin-treated patients with osteosarcoma (OS). Platform presentation, American Society of Clinical Oncology Annual Meeting, Chicago, IL. June 2012.
Womer RB, West DC, Krailo MD, Dickman PS, Pawel BR, Grier HE, Marcus K, Sailer S, Healey JH, Dormans JP, Weiss AR: A randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: A report from the Children's Oncology Group. Journal of Clinical Oncology 30: 4148-54, 2012.
van Doorninck John A, Ji Lingyun, Schaub Betty, Shimada Hiroyuki, Wing Michele R, Krailo Mark D, Lessnick Stephen L, Marina Neyssa, Triche Timothy J, Sposto Richard, Womer Richard B, Lawlor Elizabeth R: Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 28(12): 1989-94, Apr 2010.
Chou Alexander J, Kleinerman Eugenie S, Krailo Mark D, Chen Zhengjia, Betcher Donna L, Healey John H, Conrad Ernest U, Nieder Michael L, Weiner Michael A, Wells Robert J, Womer Richard B, Meyers Paul A, : Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group. Cancer 115(22): 5339-48, Nov 2009.